The model organism Drosophila melanogaster was increasingly applied in nutrition
research in recent years. A range of methods are available for the phenotyping of D …

Metabolic-associated fatty liver disease (MAFLD), the main cause of chronic liver disease
worldwide, is a progressive disease ranging from fatty liver to steatohepatitis (metabolic …

Ursodeoxycholic acid (UDCA) has been broadly adopted for the clinical treatment of hepatic
and biliary diseases; however, its poor water-solubility becomes an obstacle in wide …

Background: Aging and obesity are associated with insulin resistance (IR) and low-grade
inflammation. Molecularly, IR is characterized by a reduction in glucose uptake and insulin …

Lipid accumulation is a major factor in the development of non‐alcoholic fatty liver disease
(NAFLD). Currently, there is a lack of intervention or therapeutic drugs against NAFLD. In …

Elevated circulating fatty acids in obesity may induce hepatic steatosis, leading to liver
inflammation, fibrosis and nonalcoholic fatty liver disease (NAFLD). On the other hand …

Herbal preparations can have beneficial effects to counteract cardiovascular diseases
(CVD). Inhibition of platelet aggregation have been shown to be effective in CVD treatment …

Insects have become essential models in studying human metabolic diseases, mainly due to
their low maintenance cost and available tools. Both mutations and modified diets induce …

Background: Obesity has been increasing very rapidly over the past few decades in various
developed countries affecting human health and producing various chronic disorders like …

Introducción: la enfermedad de hígado graso no alcohólico (EHGNA) se caracteriza por la
acumulación de gotas lipídicas (GL) y sobre expresión de la proteína de GL Perilipina 1 …